Related Experiment Video
Updated: Aug 30, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Stroke prevention]
M Arnold1, K Nedeltchev, Ph Lyrer
1Neurologische Universitätskliniken Bern. marcel.arnold@insel.ch
Insights
Lifestyle changes and medications like antihypertensives and antithrombotics can reduce stroke risk. Antiplatelet agents and warfarin are key for preventing recurrent strokes and managing specific conditions.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Lifestyle modifications are crucial for reducing stroke risk.
- Several drug classes, including antihypertensives, antidiabetics, statins, and antithrombotics, are effective in managing patients with stroke risk factors.
Purpose of the Study:
- To review the pharmacological strategies for stroke risk reduction and secondary stroke prevention.
- To outline the primary and alternative medication choices for different stroke types and patient profiles.
Main Methods:
- Review of established pharmacological treatments for stroke prevention.
- Analysis of antiplatelet agents and anticoagulants in secondary stroke prevention.
Main Results:
- Antiplatelet agents (aspirin, aspirin/dipyridamole, clopidogrel) are first-line for non-cardioembolic ischemic stroke prevention.
- Warfarin is effective for cardioembolic stroke, cerebral venous thrombosis, and antiphospholipid antibody syndrome, with other potential indications.
Conclusions:
- Pharmacological interventions, tailored to stroke type and patient factors, are essential for secondary stroke prevention.
- Antiplatelet therapy and anticoagulation with warfarin represent cornerstone treatments in managing cerebrovascular disease.
Abstract:
Life style modification has been shown to reduce stroke risk. In patients with risk factors several drugs have proven their efficacy. The most effective medications are antihypertensives, antidiabetics, statins and antithrombotics. In the prevention of recurrent stroke in patients with a noncardioembolic ischemic stroke antiplatelet agents are used. Aspirin or a combination aspirin/dipyridamol are the first-line agents. Clopidogrel is recommended for patients with aspirin intolerance, several risk factors or recurrent cerebrovascular events. Warfarin has demonstrated efficacy in stroke prevention in patients with cardioembolic stroke, cerebral venous thrombosis and antiphospholipid antibody syndrome. Other, less well established indications for warfarin in the secondary prevention of stroke are: symptomatic intracranial artery stenosis; large aortic atheroma and extracranial carotid or vertebral artery dissection.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology